Gleevec, a brand of imatinib mesylate, is used in the treatment of Chronic Myeloid Leukemia, a rare form of cancer.
More information
More information
Related categories 1
Sites 5
Imatinib mesylate. Features prescribing and reimbursement information for US residents.
Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
Features information about dosage, usage, warnings, and side effects.
Features information about dosage, usage, warnings, and side effects.
Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Imatinib mesylate. Features prescribing and reimbursement information for US residents.
